Related Experiment Video
Updated: May 12, 2026

Detection of Invasive Pulmonary Aspergillosis in Haematological Malignancy Patients by using Lateral-flow Technology
Published on: March 22, 2012
Microfluidic point-of-care testing for the detection of Bordetella pertussis: A mini-review
1TUBITAK, Marmara Research Center, Kocaeli, Turkiye.
Abstract:
Bordetella pertussis is a bacterial pathogen responsible for pertussis, which is a highly contagious respiratory disease. Despite the relatively high vaccination coverage, pertussis is considered a reemerging disease that necessitates enhanced strategies for identification, prevention, and control. The diagnosis of pertussis typically involves a combination of clinical evaluation, laboratory tests, and a thorough medical history. The current technologies for pertussis diagnosis have their own limitations, prompting the exploration of alternative diagnostic approaches that offer enhanced sensitivity, specificity, and speed. Microfluidic technology is considered a very promising tool for the diagnosis of infectious diseases, as it offers more rapid and accurate outputs. It allows point-of-care testing (POCT) at or near the patient site, which can be critical, especially for an outbreak or pandemic. In this paper, current pertussis diagnostic tools with their limitations were discussed, and microfluidic approaches for the diagnosis of pertussis were highlighted.
Insights
Bordetella pertussis causes reemerging pertussis. Microfluidic technology offers rapid, accurate point-of-care testing (POCT) for improved diagnosis and control of this contagious respiratory disease.
Area of Science:
- Microbiology
- Medical Diagnostics
- Biotechnology
Background:
- Bordetella pertussis causes pertussis, a highly contagious respiratory illness.
- Pertussis is reemerging despite high vaccination rates, requiring better diagnostic strategies.
- Current diagnostic methods for pertussis have limitations in sensitivity, specificity, and speed.
Purpose of the Study:
- To discuss current pertussis diagnostic tools and their limitations.
- To highlight microfluidic approaches as a promising alternative for pertussis diagnosis.
Main Methods:
- Review of existing literature on pertussis diagnostics.
- Exploration of microfluidic technology principles and applications in infectious disease diagnosis.
Main Results:
- Current diagnostic methods for pertussis face challenges.
- Microfluidic technology demonstrates potential for rapid, sensitive, and specific pertussis detection.
- Microfluidics enables point-of-care testing (POCT), crucial for outbreak management.
Conclusions:
- Microfluidic technology presents a significant advancement for diagnosing pertussis.
- This technology can enhance the speed, accuracy, and accessibility of pertussis diagnosis.
- Microfluidics offers a pathway to improved identification, prevention, and control strategies for pertussis.
Related Concept Videos
Methods to Assess Microbial Populations
Automated Microbial Diagnostics

